Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population

This publication has 16 references indexed in Scilit:

• The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
  Journal of Clinical Investigation, 1998
• Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer Disease
  Alzheimer Disease & Associated Disorders, 1998
• Physiological and pathological roles of interleukin-6 in the central nervous system
  Molecular Neurobiology, 1997
• Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease
  Neuroscience Letters, 1997
• Transgenic models to assess the pathogenic actions of cytokines in the central nervous system
  Molecular Psychiatry, 1997
• Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal
  Neurobiology of Aging, 1996
• Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
  Journal of Affective Disorders, 1995
• Anti-inflammatory drugs and Alzheimer disease
  The Lancet, 1990
• Rapid detection and sequencing of alleles in the 3′ flanking region of the Interleukin-6 gene
  Nucleic Acids Research, 1989
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984